Clene Inc.

Pharmaceutical company · Salt Lake City, Utah, United States · Nasdaq: CLNN

Clene Inc. is a pharmaceutical company headquartered in Salt Lake City, Utah, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker CLNN. It has reported private securities offerings to the US SEC, most recently $7.3 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Clene at a glance

Typepharmaceutical company

HeadquartersSalt Lake City, Utah, United States

Earliest incorporation on record2020

Stock listingNasdaq: CLNN

SEC industryPharmaceutical Preparations

SEC CIK1822791

What does Clene do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $7.3 million sold (2024).

Frequently asked questions about Clene

Where is Clene headquartered?

Clene Inc. is headquartered in Salt Lake City, Utah, United States.

What does Clene do?

Clene Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Clene a public company?

Yes. Clene Inc. trades on Nasdaq under the ticker CLNN.

When was Clene founded?

The earliest incorporation on record for Clene Inc. is in 2020, according to public company registers.

Similar companies

iVeena Delivery Systems, Inc.Salt Lake City, Utah, United States
Lipocine Inc.Salt Lake City, Utah, United States
Usana Health Sciences IncSalt Lake City, Utah, United States
Curza, Inc.Salt Lake City, Utah, United States
Q Therapeutics, Inc.Salt Lake City, Utah, United States
Clene Nanomedicine, Inc.Salt Lake City, Utah, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences